BrainCool AB

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: SE0005731833
SEK
0.52
-0.01 (-2.08%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

52 Week

Valuation
Technical
Day's Volume

CASH

N/A

Shareholding

FII

N/A

DII

N/A

Promoter

N/A

iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Dashboard
1

Risky -

  • The stock is trading risky as compared to its average historical valuations
  • Over the past year, while the stock has generated a return of -62.26%, its profits have risen by 24%
2

Below par performance in long term as well as near term

stock-summaryMojo Parameters
Mojo Parameters
Stock DNA
stock-summary
Industry

Pharmaceuticals & Biotechnology

stock-summary
Market cap

SEK 143 Million (Micro Cap)

stock-summary
P/E

NA (Loss Making)

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

-0.06

stock-summary
Return on Equity

-31.43%

stock-summary
Price to Book

1.22

Revenue and Profits:
Net Sales:
7 Million
(Quarterly Results - Jun 2025)
Net Profit:
-11 Million
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-42.91%
0%
-42.91%
6 Months
-65.24%
0%
-65.24%
1 Year
-63.63%
0%
-63.63%
2 Years
-87.66%
0%
-87.66%
3 Years
0%
0%
0.0%
4 Years
0%
0%
0.0%
5 Years
0%
0%
0.0%

BrainCool AB for the last several years.

Risk Adjusted Returns v/s stock-summary
stock-summaryNews & Corporate Actions
News
Icon
No Recent News for the Company
Announcements stock-summary
Icon
No announcement available
Corporate Actions stock-summary
Icon
No corporate action available
stock-summaryKey Factors
Quality key factors stock-summary
Factor
Value
Sales Growth (5y)
44.60%
EBIT Growth (5y)
2.67%
EBIT to Interest (avg)
-25.23
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-0.06
Sales to Capital Employed (avg)
0.25
Tax Ratio
0.55%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
0
ROE (avg)
0
Valuation key factors
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
1.62
EV to EBIT
-5.05
EV to EBITDA
-5.58
EV to Capital Employed
1.67
EV to Sales
5.11
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-32.98%
ROE (Latest)
-30.75%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Bearish
Bearish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Dow Theory
Bearish
No Trend
OBV
Mildly Bullish
No Trend
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshotstock-summary
Icon
No data for shareholding present.
Shareholding Compare (%holding) stock-summary
Icon
No data for shareholding present.
stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Jun'25 - YoY",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in quarter ended Jun 2025 is -37.14% vs 41.89% in Jun 2024",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in quarter ended Jun 2025 is 15.62% vs -0.79% in Jun 2024",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Jun'25",
        "Jun'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "6.60",
          "val2": "10.50",
          "chgp": "-37.14%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-10.20",
          "val2": "-12.00",
          "chgp": "15.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-10.80",
          "val2": "-12.80",
          "chgp": "15.62%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-1,687.00%",
          "val2": "-1,192.30%",
          "chgp": "-49.47%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2024 is 72.41% vs 31.82% in Dec 2023",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2024 is 28.22% vs -34.43% in Dec 2023",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "40.00",
          "val2": "23.20",
          "chgp": "72.41%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-41.50",
          "val2": "-53.10",
          "chgp": "21.85%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "7.00",
          "val2": "0.20",
          "chgp": "3,400.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "-6.50",
          "chgp": "100.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-44.00",
          "val2": "-61.30",
          "chgp": "28.22%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-1,106.40%",
          "val2": "-2,385.90%",
          "chgp": "127.95%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]
Quarterly Results Snapshot (Consolidated) - Jun'25 - YoYstock-summary
Jun'25
Jun'24
Change(%)
Net Sales
6.60
10.50
-37.14%
Operating Profit (PBDIT) excl Other Income
-10.20
-12.00
15.00%
Interest
0.00
0.00
Exceptional Items
0.00
0.00
Consolidate Net Profit
-10.80
-12.80
15.62%
Operating Profit Margin (Excl OI)
-1,687.00%
-1,192.30%
-49.47%
USD in Million.
Direction Arrows
Net Sales

YoY Growth in quarter ended Jun 2025 is -37.14% vs 41.89% in Jun 2024

Direction Arrows
Consolidated Net Profit

YoY Growth in quarter ended Jun 2025 is 15.62% vs -0.79% in Jun 2024

Annual Results Snapshot (Consolidated) - Dec'24stock-summary
Dec'24
Dec'23
Change(%)
Net Sales
40.00
23.20
72.41%
Operating Profit (PBDIT) excl Other Income
-41.50
-53.10
21.85%
Interest
7.00
0.20
3,400.00%
Exceptional Items
0.00
-6.50
100.00%
Consolidate Net Profit
-44.00
-61.30
28.22%
Operating Profit Margin (Excl OI)
-1,106.40%
-2,385.90%
127.95%
USD in Million.
Direction Arrows
Net Sales

YoY Growth in year ended Dec 2024 is 72.41% vs 31.82% in Dec 2023

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Dec 2024 is 28.22% vs -34.43% in Dec 2023

stock-summaryCompany CV
About BrainCool AB stock-summary
stock-summary
BrainCool AB
Pharmaceuticals & Biotechnology
BrainCool publ AB is a Sweden-based company active in the healthcare sector. It develops a medical device for therapeutic brain cooling. BrainCool publ AB uses a patented cooling method developed by Dignitana AB, the marker of the DigniCap System for the prevention of chemotherapy-related hair loss. The technology used in the BrainCool System allows cooling of the neck, which helps to speed perfusion and cooling of blood before it reaches the brain. The therapeutic hypothermia device is dedicated to patients suffering from stroke, cardiac arrest, traumatic brain injury or neonatal asphyxia. BrainCool publ AB is a wholly owned subsidiary of Dignitana AB.
Company Coordinates stock-summary
Company Details
Medicon Village, Scheelevagen 2 , LUND None : 223 81
stock-summary
Tel: 46 73 3937076
stock-summary
Registrar Details